Thrombolytic (Fibrinolytic) Therapy for Coronary Heart Disease

Thrombolytic Therapy for Arterial Disease

Pearls 1. Patient workup and evaluation is key to a successful intervention while limiting complications. In addition to physical exam and laboratory evaluation, review of prior imaging studies and surgical interventions is important to understanding the etiology of the occlusion and to guide therapy. 2. Use of arterial thrombolysis should be avoided in patients with evidence of irreversible li...

Fibrinolytic Therapy of Coronary Thrombosis.

Coronary disease ADJUNCTIVE TREATMENT IN PATIENTS TREATED WITH THROMBOLYTIC THERAPY

Correspondence to: Professor F W A Verheugt, University Medical Center St Radboud, Heartcenter, 540 Cardiology, PO Box 9101, Nijmegen, The Netherlands 6500 HB; f.verheugt@cardio. umcn.nl _________________________ T hrombotic occlusion of an epicardial coronary artery has been implicated as a potential mechanism involved in acute myocardial infarction since as early as 1910, and became generally...

Cognitive Behavioral Group Therapy and Coping Styles in Patients with Acute Coronary Heart Disease

Objectives: The present study has investigated the effect of cognitive behavioral group therapy on improving coping styles in patients with acute coronary heart disease. Methods: Semi-experimental in type of pretest-posttest with control group seems to be a good design for this study.22 patients with acute coronary heart disease are admitted in CCU of Mashhad Razavi Hospital and undergo angi...

Antithrombotic and Thrombolytic Therapy for Valvular Disease

We were pleased to read the article by Whitlock et al 1 in the February 2012 supplement issue of CHEST . They concluded, “In patients with a mechanical mitral valve (both the aortic and mitral position), we suggest [vitamin K antagonist] therapy with a target [international normalized ratio (INR)] of 3.0 (range, 2.5-3.5).” 1 However, we have several concerns about their conclusion. First, thro...